| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241095 | Respiratory Medicine | 2016 | 52 Pages |
Abstract
Tiotropium Respimat® demonstrated safety and tolerability comparable with those of placebo, as add-on to at least ICS therapy, at different treatment steps in adults with symptomatic asthma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
Ronald Dahl, Michael Engel, Daniel Dusser, David Halpin, Huib A.M. Kerstjens, Liliana Zaremba-Pechmann, Petra Moroni-Zentgraf, William W. Busse, Eric D. Bateman,